Mark S Leventhal, a director of ProPhase Labs, recently acquired 145,309 shares of the company. The buys took place at $1.61 per share, on August 18, 2015. Leventhal now owns 1,012,180 shares of the company. Leventhal operates out of Doylestown, PA. Some additional info was provided as follows:
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.61, inclusive.
The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The above information was disc losed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
ProPhase Labs's Chief Financial Officer just picked up 360,000 shares - Sept. 15, 2017
Tender offer statement by Issuer - Aug. 25, 2017
Departure of Directors or Certain - Aug. 24, 2017